MR

MRK MERCK & CO. INC.

2026Q2 · CUSIP 58933Y105 · Big Pharma · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
3,809
Institutions that reported holding it to the SEC
Net increase in holders
+47
Last quarter 3,762 → now 3,809
How unusual is that
Top 10%
Stronger buying than 91% of US stocks
What the filings say, in one paragraph

3,809 funds held MRK at the end of 2026Q2, up 47 from the quarter before. That is stronger buying than 91.4% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $66.6B(YoY +4.6%), the P/E is 112.5x, return on equity is 7.6%. MRK has had 33 buying rushes in its history, and the price moved +3.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector, tagged Big Pharma.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=1281 2013Q4: holders=1364 2014Q1: holders=1407 2014Q2: holders=1423 2014Q3: holders=1426 2014Q4: holders=1518 2015Q1: holders=1532 2015Q2: holders=1540 2015Q3: holders=1497 2015Q4: holders=1575 2016Q1: holders=1573 2016Q2: holders=1597 2016Q3: holders=1659 2016Q4: holders=1760 2017Q1: holders=1793 2017Q2: holders=1780 2017Q3: holders=1782 2017Q4: holders=1871 2018Q1: holders=1862 2018Q2: holders=1883 2018Q3: holders=1923 2018Q4: holders=2110 2019Q1: holders=2161 2019Q2: holders=2174 2019Q3: holders=2193 2019Q4: holders=2418 2020Q1: holders=2365 2020Q2: holders=2393 2020Q3: holders=2458 2020Q4: holders=2608 2021Q1: holders=2579 2021Q2: holders=2572 2021Q3: holders=2553 2021Q4: holders=2814 2022Q1: holders=2864 2022Q2: holders=2930 2022Q3: holders=2898 2022Q4: holders=3149 2023Q1: holders=3100 2023Q2: holders=3177 2023Q3: holders=3141 2023Q4: holders=3365 2024Q1: holders=3469 2024Q2: holders=3478 2024Q3: holders=3430 2024Q4: holders=3543 2025Q1: holders=3391 2025Q2: holders=3269 2025Q3: holders=3255 2025Q4: holders=3619 2026Q1: holders=3762 2026Q2: holders=3809 -364 -182 +0 +182 +364 115225764000 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 33 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 10% — —
2026Q1 Top 1% in the market +13.4% +32.8%
2025Q4 Top 1% in the market -1.4% -6.6%
2024Q4 Top 5% +5.2% -7.6%
2024Q1 Top 1% in the market -3.0% -12.3%
2023Q4 Top 1% in the market +0.5% +3.3%
2023Q2 Top 1% in the market -5.0% -5.4%
2022Q4 Top 1% in the market +2.9% +7.8%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
410
Change in large funds
+43
Total value they hold
$254.7B
Funds buying for the first time
220
Funds that sold out entirely
173
Price change that quarter
+21.7%
Funds holding puts (bearish)
50
Funds holding calls (bullish)
52

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

Fundamentals

PE (TTM)
112.5
EPS (TTM)
$1.25
EPS YoY
-80.8%
Revenue (TTM)
$66.6B
Revenue YoY
+4.6%
Net margin
4.8%
ROE
7.6%
Debt ratio
67.7%
FCF (TTM)
$16.1B
Dividend (TTM)
$3.36
Quarterly Revenue & EPS
2021-09-30: EPS 1.80 2021-12-31: EPS 1.48 2022-03-31: EPS 1.70 2022-06-30: EPS 1.55 2022-09-30: EPS 1.28 2022-12-31: EPS 1.18 2023-03-31: EPS 1.11 2023-06-30: EPS -2.35 2023-09-30: EPS 1.86 2023-12-31: EPS -0.48 2024-03-31: EPS 1.87 2024-06-30: EPS 2.14 2024-09-30: EPS 1.24 2024-12-31: EPS 1.49 2025-03-31: EPS 2.01 2025-06-30: EPS 1.76 2025-09-30: EPS 2.32 2025-12-31: EPS 1.19 2026-03-31: EPS -1.72 2026-06-30: EPS -0.54 0B 8.6B 17.3B $B -2.59 -0.02 2.55 201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 19 10 448 886 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-1.6B3.4B8.5B 20162017201820192020202120222023202420252026
Latest quarter $2.9B (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.